Fluidization of a Dipalmitoyl Phosphatidylcholine Monolayer by Fluorocarbon Gases: Potential Use in Lung Surfactant Therapy

Riess, 2004, 521 Riess, 2001, Oxygen carriers (“Blood substitutes”)—Raison d’être, chemistry, and some physiology, Chem. Rev., 101, 2797, 10.1021/cr970143c Schutt, 2003, Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals, Angew. Chem. Int. Ed. Engl., 42, 3218, 10.1002/anie.200200550 Wolfson, 1998, Perfluorochemical rescue after surfactant treatment: effect of perflubron dose and ventilatory frequency, J. Appl. Physiol., 84, 624, 10.1152/jappl.1998.84.2.624 Leach, 1996, Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome, N. Engl. J. Med., 335, 761, 10.1056/NEJM199609123351101 Sukumar, 1998, High-frequency partial liquid ventilation in respiratory distress syndrome: hemodynamics and gas exchange, J. Appl. Physiol., 84, 327, 10.1152/jappl.1998.84.1.327 Croce, 1998, Partial liquid ventilation decreases the inflammatory response in the alveolar environment of trauma patients, J. Trauma, 45, 273, 10.1097/00005373-199808000-00012 Koch, 2001, Perfluorohexane attenuates proinflammatory and procoagulatory response of activated monocytes and alveolar macrophages, Anesthesiology, 94, 101, 10.1097/00000542-200101000-00020 Bleyl, 1999, Vaporized perfluorocarbon improves oxygenation and pulmonary function in an ovine model of acute respiratory distress syndrome, Anesthesiology, 91, 461, 10.1097/00000542-199908000-00021 Bleyl, 2002, Changes in pulmonary function and oxygenation during application of perfluorocarbon vapor in healthy and oleic acid-injured animals, Crit. Care Med., 30, 1340, 10.1097/00003246-200206000-00034 Zasadzinski, 2001, The physics and physiology of lung surfactants, Curr. Opin. Colloid Interf. Sci., 6, 506, 10.1016/S1359-0294(01)00124-8 Hills, 1988 Wright, 1989, Pulmonary surfactant metabolism, Clin. Chest Med., 10, 83, 10.1016/S0272-5231(21)00606-7 Rooney, 2001, Regulation of surfactant secretion, Comp. Biochem. Physiol. A., 129, 233, 10.1016/S1095-6433(01)00320-8 Rüdiger, 2005, Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity, Am. J. Physiol. Lung Cell. Mol. Physiol., 288, L379, 10.1152/ajplung.00176.2004 Possmayer, 1984, Pulmonary surfactant, Can. J. Biochem. Cell Biol., 62, 1121, 10.1139/o84-146 Goerke, 1998, Pulmonary surfactant: functions and molecular composition, Biochim. Biophys. Acta, 1408, 79, 10.1016/S0925-4439(98)00060-X Clements, 1961, Pulmonary surface tension and alveolar stability, J. Appl. Physiol., 16, 444, 10.1152/jappl.1961.16.3.444 Rüdiger, 2003 Post, 1995, Pulmonary surfactant protein C-containing lipid films at the air-water interface as a model for the surface of lung alveoli, Mol. Membr. Biol., 12, 93, 10.3109/09687689509038502 Schürch, 1995, The surface-associated surfactant reservoir in the alveolar lining, Biol. Neonate, 67, 61, 10.1159/000244207 Ding, 2001, Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayer stability, Biophys. J., 80, 2262, 10.1016/S0006-3495(01)76198-X Takamoto, 2001, Interaction of lung surfactant proteins with anionic phospholipids, Biophys. J., 81, 153, 10.1016/S0006-3495(01)75688-3 Ding, 2003, Nanostructure changes in lung surfactant monolayers induced by interactions between palmitoyloleoylphosphatidylcholine and surfactant protein B, Langmuir, 19, 1539, 10.1021/la0261794 Spragg, 1987, The future for surfactant therapy of the adult respiratory distress syndrome., 203 Banerjee, 2002, Surface chemistry of the lung surfactant system: techniques for in vitro evaluation, Curr. Sci., 82, 420 Riess, 2002, Fluorous micro- and nanophases with a biomedical perspective, Tetrahedron, 58, 4113, 10.1016/S0040-4020(02)00262-4 Fontaine, 2004, Fast and adjustable-resolution grazing-incidence x-ray liquid surface diffraction, Rev. Sci. Instrum., 75, 3097, 10.1063/1.1790582 Als-Nielsen, 1994, Principles and applications of grazing incidence x-ray and neutron scattering from ordered molecular monolayers at the air-water interface, Phys. Rep., 246, 251, 10.1016/0370-1573(94)90046-9 Kaganer, 1999, Structure and phase transitions in Langmuir monolayers, Rev. Mod. Phys., 71, 779, 10.1103/RevModPhys.71.779 Lösche, 1983, Fluorescence microscopic study concerning the phase diagram of phospholipids, Ber. Bunsenges. Phys. Chem. Chem. Phys., 87, 848, 10.1002/bbpc.19830871004 Albrecht, 1978, Polymorphism of phospholipid monolayers, J. Phys. (Paris), 39, 301, 10.1051/jphys:01978003903030100 Ivanova, 2004, Dilatational properties and morphology of surface films spread from clinically used lung surfactants, Colloid Polym. Sci., 282, 1258, 10.1007/s00396-004-1073-8 Brezesinski, 1996, Structural changes of monolayers at the air/water interface contacted with n-alkanes, J. Phys. Chem., 100, 3126, 10.1021/jp952117t Unger, 2004, Therapeutic applications of lipid-coated microbubbles, Adv. Drug Deliv. Rev., 56, 1291, 10.1016/j.addr.2003.12.006 Gerber, F., M. P. Krafft, G. Waton, and T. F. Vandamme., 2006. Microbubbles with exceptionally long life—synergy between shell and internal phase components. New J. Chem. doi:10.1039/b600061b. Reference deleted in proof. Bernhard, 2000, Commercial versus native surfactants surface activity, molecular components, and the effect of calcium, Am. J. Respir. Crit. Care Med., 162, 1524, 10.1164/ajrccm.162.4.9908104 Knobler, 1992, Phase transitions in monolayers, Annu. Rev. Phys. Chem., 43, 207, 10.1146/annurev.pc.43.100192.001231